|
| 1 |
Drug Repositioning for Treatment of Head and Neck Cancers
Minsu Kwon
|
|
| 2 |
Infection of the Cavernous Sinus Caused by Candida auris
Seo Hu Lee, So Yeon Park, Jin Seo Lee, Jihyu Oh
|
|
| 3 |
Epidemiology of PAH in Korea: An Analysis of the National Health Insurance Data, 2002–2018
Albert Youngwoo Jang, Hyeok-Hee Lee, Hokyou Lee, Hyeon Chang Kim, Wook-Jin Chung
Korean Circ J.2023;53(5):313-327. Published online 2023 March 8
DOI: http://dx.doi.org/10.4070/kcj.2022.0231
|
|
| 4 |
No more tears from surgical site infections in interventional pain management
Seungjin Lim, Yeong-Min Yoo, Kyung-Hoon Kim
Korean J Pain.2023;36(1):11-50. Published online 2023 January 1
DOI: http://dx.doi.org/10.3344/kjp.22397
|
|
| 5 |
Effect of the addition of thiazolidinedione to sodium-glucose cotransporter 2 inhibitor therapy on lipid levels in type 2 diabetes mellitus: a retrospective study using Korean National Health Insurance Service data
Taegyun Park, Kyungdo Han, Dongwook Shin, Jongho Park
|
|
| 6 |
Assessment on Treatments With Conventional Synthetic Disease-modifying Drugs Before Initiating Biologics in Patients With Rheumatoid Arthritis in Korea: A Population-based Study
Min Jung Kim, Eun Hye Park, Anna Shin, You-Jung Ha, Yun Jong Lee, Eun Bong Lee, Han Joo Baek, Eun Ha Kang
|
|
| 7 |
A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non–Small Cell Lung Cancer
Eo Jin Kim, Yong-Hee Cho, Dong Ha Kim, Dae-Hyun Ko, Eun-Ju Do, Sang-Yeob Kim, Yong Man Kim, Jae Seob Jung, Yoonmi Kang, Wonjun Ji, Myeong Geun Choi, Jae Cheol Lee, Jin Kyung Rho, Chang-Min Choi
Cancer Res Treat.2022;54(4):1005-1016. Published online 2021 December 3
DOI: http://dx.doi.org/10.4143/crt.2021.986
|
|
| 8 |
Treatment Effect of Combining Lenvatinib and Vemurafenib for BRAF Mutated Anaplastic Thyroid Cancer
Chae Moon Hong, Ji Min Oh, Prakash Gangadaran, Ramya Lakshmi Rajendran, Byeong-Cheol Ahn
|
|
| 9 |
Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non–Small Cell Lung Cancer
Shinkyo Yoon, Hannah Yang, Hyun-Min Ryu, Eunjin Lee, Yujin Jo, Seyoung Seo, Deokhoon Kim, Chang Hoon Lee, Wanlim Kim, Kyung Hae Jung, Sook Ryun Park, Eun Kyung Choi, Sang-We Kim, Kang-Seo Park, Dae Ho Lee
Cancer Res Treat.2022;54(3):767-781. Published online 2021 September 30
DOI: http://dx.doi.org/10.4143/crt.2021.651
|
|
| 10 |
T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity
Wilmar M. Wiersinga
Endocrinol Metab.2021;36(5):938-951. Published online 2021 September 30
DOI: http://dx.doi.org/10.3803/EnM.2021.501
|
|
| 11 |
Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer
Hye-Rim Seo, Ah-Rong Nam, Ju-Hee Bang, Kyoung-Seok Oh, Jae-Min Kim, Jeesun Yoon, Tae-Yong Kim, Do-Youn Oh
Cancer Res Treat.2022;54(2):541-553. Published online 2021 August 6
DOI: http://dx.doi.org/10.4143/crt.2021.473
|
|
| 12 |
Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease
Anthony Buisson, Lisa Cannon, Konstantin Umanskiy, Roger D. Hurst, Neil H. Hyman, Atsushi Sakuraba, Joel Pekow, Sushila Dalal, Russell D. Cohen, Bruno Pereira, David T. Rubin
Intest Res.2022;20(3):303-312. Published online 2021 August 4
DOI: http://dx.doi.org/10.5217/ir.2021.00018
|
|
| 13 |
Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Soon-Jib Yoo, Sang-Ah Chang, Tae Seo Sohn, Hyuk-Sang Kwon, Jong Min Lee, Sungdae Moon, Pieter Proot, Päivi M Paldánius, Kun Ho Yoon
Diabetes Metab J.2021;45(6):954-959. Published online 2020 November 12
DOI: http://dx.doi.org/10.4093/dmj.2020.0173
|
|
| 14 |
Nonalcoholic Fatty Liver Disease: A Drug Revolution Is Coming
Soung Won Jeong
Diabetes Metab J.2020;44(5):640-657. Published online 2020 October 21
DOI: http://dx.doi.org/10.4093/dmj.2020.0115
|
|
| 15 |
Evaluating the Evidence behind the Novel Strategy of Early Combination from Vision to Implementation
Päivi Maria Paldánius
Diabetes Metab J.2020;44(6):785-801. Published online 2020 September 15
DOI: http://dx.doi.org/10.4093/dmj.2020.0179
|
|
| 16 |
Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study
Jun Sung Moon, Sunghwan Suh, Sang Soo Kim, Heung Yong Jin, Jeong Mi Kim, Min Hee Jang, Kyung Ae Lee, Ju Hyung Lee, Seung Min Chung, Young Sang Lyu, Jin Hwa Kim, Sang Yong Kim, Jung Eun Jang, Tae Nyun Kim, Sung Woo Kim, Eonju Jeon, Nan Hee Cho, Mi-Kyung Kim, Hye Soon Kim, Il Seong Nam-Goong, Eun Sook Kim, Jin Ook Chung, Dong-Hyeok Cho, Chang Won Lee, Young Il Kim, Dong Jin Chung, Kyu Chang Won, In Joo Kim, Tae Sun Park, Duk Kyu Kim, Hosang Shon
Diabetes Metab J.2021;45(5):675-683. Published online 2020 August 12
DOI: http://dx.doi.org/10.4093/dmj.2020.0107
|
|
| 17 |
Long-Term Current Management of Enduring Obesity in Diabetes
Chong Hwa Kim
|
|
| 18 |
Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects
Eunsol Yang, Soyoung Lee, Heechan Lee, Inyoung Hwang, In-Jin Jang, Kyung-Sang Yu, SeungHwan Lee
|
|
| 19 |
Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes
Han Na Jang, Ye Seul Yang, Seong Ok Lee, Tae Jung Oh, Bo Kyung Koo, Hye Seung Jung
|
|
| 20 |
Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
Kyu Yong Cho, Akinobu Nakamura, Chiho Oba-Yamamoto, Kazuhisa Tsuchida, Shingo Yanagiya, Naoki Manda, Yoshio Kurihara, Shin Aoki, Tatsuya Atsumi, Hideaki Miyoshi
Diabetes Metab J.2020;44(4):532-541. Published online 2019 November 22
DOI: http://dx.doi.org/10.4093/dmj.2019.0093
|
|
